Hi Yank tank,
Not all stem cells are the same.
Mesoblasts cells have a long track record of efficiency in various indications.
This indication is just one of many which MSB are hoping to gain FDA approval for.
For me being involved with this share,I feel 100% that the results from the release
will be replicated in larger numbers.
Time to stop doubting SI start getting positive.
It was fun watching the trader dummies thinking, oh its got to $2.50 better sell it down.
They just got eaten. It not a traders stock anymore . People are about to learn that,
maybe the hard way.
Aloha.
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-450
-
- There are more pages in this discussion • 398 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.38 |
Change
-0.080(5.50%) |
Mkt cap ! $1.587B | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.43 | $1.37 | $4.023M | 2.884M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 44575 | $1.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.38 | 89904 | 15 |
View Market Depth
| Last trade - 14.31pm 16/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |